An investigation into the potential of SarAr for use in 64 Cu radioimmunotherapy
The B72.3 monoclonal antibody was radiolabelled with 123I, and with 111In and 64Cu, using DTPA and SarAr, respectively. Their biodistribution in tumour-bearing nude mice was used to calculate the dosimetry of their respective therapeutic analogue, using 131I, 90Y, 67Cu, and 64Cu. Two dosimetry models were used: one using the classical approach and a second model that takes into consideration the chemical stability of the radiolabelling methods employed and the biological clearance of each...[Show more]
|Collections||ANU Research Publications|
|Source:||Australian Journal of Chemistry|
|01_Di Bartolo_An_investigation_into_the_2009.pdf||296.25 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.